Japan Sets Conflict Rules For Outside Drug Reviewers
This article was originally published in The Pink Sheet Daily
Executive Summary
Final reg covers clinical trial, product approval and examination-related consultation and advice on pharmaceuticals, medical devices and related products.
You may also be interested in...
Focused On Globalization, Shanghai FDA Will Hold International Forum On Drug Safety And Regulatory Change
BEIJING - In an effort to fast-forward the globalization of China's drug laws and utlimately boost its exports of pharmaceuticals, the Shanghai FDA is partnering with a U.S.-based law firm to co-host its first international forum on drug safety and regulatory change
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products
More Reform Eyed For Japan's OTC Deregulation
Japan's executive branch will urge the country's drug regulators to relax recently imposed limits on online sales of OTC products